Cargando…

Liver lymphatic anatomy and role in systemic lymphatic disease

OBJECTIVES: To characterize hepatic to systemic lymphatic connections in patients with systemic lymphatic disease using intra-hepatic lymphangiography and to compare outcomes after lymphatic intervention. METHODS: In this retrospective study, patients with intra-hepatic lymphangiography from May 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Christopher L., Liu, Mandi, Saravanan, Madhumitha, Dewitt, Aaron G., Biko, David M., Pinto, Erin M., Escobar, Fernando A., Krishnamurthy, Ganesh, Brownell, Jefferson N., Mamula, Petar, Glatz, Andrew C., Gillespie, Matthew J., O’Byrne, Michael L., Ravishankar, Chitra, Rome, Jonathan J., Dori, Yoav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660706/
https://www.ncbi.nlm.nih.gov/pubmed/34165621
http://dx.doi.org/10.1007/s00330-021-08098-z
_version_ 1784613244146548736
author Smith, Christopher L.
Liu, Mandi
Saravanan, Madhumitha
Dewitt, Aaron G.
Biko, David M.
Pinto, Erin M.
Escobar, Fernando A.
Krishnamurthy, Ganesh
Brownell, Jefferson N.
Mamula, Petar
Glatz, Andrew C.
Gillespie, Matthew J.
O’Byrne, Michael L.
Ravishankar, Chitra
Rome, Jonathan J.
Dori, Yoav
author_facet Smith, Christopher L.
Liu, Mandi
Saravanan, Madhumitha
Dewitt, Aaron G.
Biko, David M.
Pinto, Erin M.
Escobar, Fernando A.
Krishnamurthy, Ganesh
Brownell, Jefferson N.
Mamula, Petar
Glatz, Andrew C.
Gillespie, Matthew J.
O’Byrne, Michael L.
Ravishankar, Chitra
Rome, Jonathan J.
Dori, Yoav
author_sort Smith, Christopher L.
collection PubMed
description OBJECTIVES: To characterize hepatic to systemic lymphatic connections in patients with systemic lymphatic disease using intra-hepatic lymphangiography and to compare outcomes after lymphatic intervention. METHODS: In this retrospective study, patients with intra-hepatic lymphangiography from May 2014 – April 2019 at our institution were included. Imaging review was performed and hepatic lymphatic connections and flow patterns were characterized. Clinical data were reviewed and comparisons between patients undergoing lymphatic intervention with or without abnormal hepatic lymphatics were performed. RESULTS: During the study period, 105 patients underwent intra-hepatic lymphangiography. Primary clinical presentation included ascites (19/105), chylothorax (27/105), plastic bronchitis (PB) (17/105), and protein losing enteropathy (PLE) (42/105). Five categories of hepatic lymphatic connections and flow patterns were identified (%): normal (25%, 26/105), hepatoperitoneal (12%, 13/105), hepatopulmonary (10.5%, 11/105), hepatomesenteric (7.5%, 8/105), and hepatoduodenal (41%, 43/105) with four patients having more than one abnormal pattern. A comparison between clinical presentation and imaging category revealed an increased likelihood of having ascites with hepatoperitoneal (p < .0001), chylothorax/PB with hepatopulmonary (p = .01), and PLE with hepatoduodenal (p < .001) connections. Seventy-six patients had a lymphatic intervention, 24% with normal, and 76% with abnormal liver lymphatics. There was no difference in length of hospital stay or mortality between the two groups, but there was a prolonged time to symptom resolution (p = .006) and persistent symptoms after 6 months (5% vs 44%, p = .002) in the group with abnormal liver lymphatics. CONCLUSION: We identified five liver lymphatic imaging categories with a substantial correlation to presenting lymphatic disease. Abnormal imaging patterns correlated with increased morbidity. Evaluation of liver lymphatics should be considered in patients with a systemic lymphatic disease if central lymphatic imaging is normal. KEY POINTS: • We identified five liver lymphatic imaging patterns: normal, hepatoperitoneal, hepatomesenteric, hepatopulmonary, and hepatoduodenal. • Imaging patterns were correlated with disease presentation (normal – chylothorax/PB, hepatoperitoneal – ascites/chylothorax, hepatopulmonary – chylothorax/PB, hepatoduodenal – PLE). • Abnormal imaging patterns correlated with increased morbidity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-021-08098-z.
format Online
Article
Text
id pubmed-8660706
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-86607062021-12-27 Liver lymphatic anatomy and role in systemic lymphatic disease Smith, Christopher L. Liu, Mandi Saravanan, Madhumitha Dewitt, Aaron G. Biko, David M. Pinto, Erin M. Escobar, Fernando A. Krishnamurthy, Ganesh Brownell, Jefferson N. Mamula, Petar Glatz, Andrew C. Gillespie, Matthew J. O’Byrne, Michael L. Ravishankar, Chitra Rome, Jonathan J. Dori, Yoav Eur Radiol Paediatric OBJECTIVES: To characterize hepatic to systemic lymphatic connections in patients with systemic lymphatic disease using intra-hepatic lymphangiography and to compare outcomes after lymphatic intervention. METHODS: In this retrospective study, patients with intra-hepatic lymphangiography from May 2014 – April 2019 at our institution were included. Imaging review was performed and hepatic lymphatic connections and flow patterns were characterized. Clinical data were reviewed and comparisons between patients undergoing lymphatic intervention with or without abnormal hepatic lymphatics were performed. RESULTS: During the study period, 105 patients underwent intra-hepatic lymphangiography. Primary clinical presentation included ascites (19/105), chylothorax (27/105), plastic bronchitis (PB) (17/105), and protein losing enteropathy (PLE) (42/105). Five categories of hepatic lymphatic connections and flow patterns were identified (%): normal (25%, 26/105), hepatoperitoneal (12%, 13/105), hepatopulmonary (10.5%, 11/105), hepatomesenteric (7.5%, 8/105), and hepatoduodenal (41%, 43/105) with four patients having more than one abnormal pattern. A comparison between clinical presentation and imaging category revealed an increased likelihood of having ascites with hepatoperitoneal (p < .0001), chylothorax/PB with hepatopulmonary (p = .01), and PLE with hepatoduodenal (p < .001) connections. Seventy-six patients had a lymphatic intervention, 24% with normal, and 76% with abnormal liver lymphatics. There was no difference in length of hospital stay or mortality between the two groups, but there was a prolonged time to symptom resolution (p = .006) and persistent symptoms after 6 months (5% vs 44%, p = .002) in the group with abnormal liver lymphatics. CONCLUSION: We identified five liver lymphatic imaging categories with a substantial correlation to presenting lymphatic disease. Abnormal imaging patterns correlated with increased morbidity. Evaluation of liver lymphatics should be considered in patients with a systemic lymphatic disease if central lymphatic imaging is normal. KEY POINTS: • We identified five liver lymphatic imaging patterns: normal, hepatoperitoneal, hepatomesenteric, hepatopulmonary, and hepatoduodenal. • Imaging patterns were correlated with disease presentation (normal – chylothorax/PB, hepatoperitoneal – ascites/chylothorax, hepatopulmonary – chylothorax/PB, hepatoduodenal – PLE). • Abnormal imaging patterns correlated with increased morbidity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-021-08098-z. Springer Berlin Heidelberg 2021-06-24 2022 /pmc/articles/PMC8660706/ /pubmed/34165621 http://dx.doi.org/10.1007/s00330-021-08098-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Paediatric
Smith, Christopher L.
Liu, Mandi
Saravanan, Madhumitha
Dewitt, Aaron G.
Biko, David M.
Pinto, Erin M.
Escobar, Fernando A.
Krishnamurthy, Ganesh
Brownell, Jefferson N.
Mamula, Petar
Glatz, Andrew C.
Gillespie, Matthew J.
O’Byrne, Michael L.
Ravishankar, Chitra
Rome, Jonathan J.
Dori, Yoav
Liver lymphatic anatomy and role in systemic lymphatic disease
title Liver lymphatic anatomy and role in systemic lymphatic disease
title_full Liver lymphatic anatomy and role in systemic lymphatic disease
title_fullStr Liver lymphatic anatomy and role in systemic lymphatic disease
title_full_unstemmed Liver lymphatic anatomy and role in systemic lymphatic disease
title_short Liver lymphatic anatomy and role in systemic lymphatic disease
title_sort liver lymphatic anatomy and role in systemic lymphatic disease
topic Paediatric
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660706/
https://www.ncbi.nlm.nih.gov/pubmed/34165621
http://dx.doi.org/10.1007/s00330-021-08098-z
work_keys_str_mv AT smithchristopherl liverlymphaticanatomyandroleinsystemiclymphaticdisease
AT liumandi liverlymphaticanatomyandroleinsystemiclymphaticdisease
AT saravananmadhumitha liverlymphaticanatomyandroleinsystemiclymphaticdisease
AT dewittaarong liverlymphaticanatomyandroleinsystemiclymphaticdisease
AT bikodavidm liverlymphaticanatomyandroleinsystemiclymphaticdisease
AT pintoerinm liverlymphaticanatomyandroleinsystemiclymphaticdisease
AT escobarfernandoa liverlymphaticanatomyandroleinsystemiclymphaticdisease
AT krishnamurthyganesh liverlymphaticanatomyandroleinsystemiclymphaticdisease
AT brownelljeffersonn liverlymphaticanatomyandroleinsystemiclymphaticdisease
AT mamulapetar liverlymphaticanatomyandroleinsystemiclymphaticdisease
AT glatzandrewc liverlymphaticanatomyandroleinsystemiclymphaticdisease
AT gillespiematthewj liverlymphaticanatomyandroleinsystemiclymphaticdisease
AT obyrnemichaell liverlymphaticanatomyandroleinsystemiclymphaticdisease
AT ravishankarchitra liverlymphaticanatomyandroleinsystemiclymphaticdisease
AT romejonathanj liverlymphaticanatomyandroleinsystemiclymphaticdisease
AT doriyoav liverlymphaticanatomyandroleinsystemiclymphaticdisease